상세 보기
Angiotensin converting enzyme inhibitors remain the first treatment of choice
- Oh, Pyung Chun;
- Sakuma, Ichiro;
- Hayashi, Toshio;
- Koh, Kwang Kon
Citations
WEB OF SCIENCE
4Citations
SCOPUS
4초록
Angiotensin converting enzyme (ACE) inhibitors (ACEIs) are beneficial and are strongly recommended for patients with acute myocardial infarction (MI) associated with heart failure, left ventricular systolic dysfunction, or preserved left ventricular systolic function. A number of clinical trials have demonstrated the benefits of ACEIs in such patients [1,2].
키워드
ELEVATION MYOCARDIAL-INFARCTION; RECEPTOR BLOCKERS; INCREASE RISK; RAMIPRIL
- 제목
- Angiotensin converting enzyme inhibitors remain the first treatment of choice
- 저자
- Oh, Pyung Chun; Sakuma, Ichiro; Hayashi, Toshio; Koh, Kwang Kon
- 발행일
- 2016-03
- 유형
- Editorial Material
- 권
- 31
- 호
- 2
- 페이지
- 237 ~ 241
- 언어
- ENG
- 출판사
- KOREAN ASSOC INTERNAL MEDICINE
- 발행국가
- 대한민국
- 분량
- 5 페이지
- ISSN
- E 2005-6648
P 1226-3303